Find out all the latest news and information from Collins Street Asset Management including quarterly reports and other recommended readings.
Paradigm Biopharmaceuticals (PAR.ASX) have $108M in cash, no debt and are well advanced in the progression of clinical trials in
While fully aware that very few commentators offering their opinion on the health and financial implications of COVID-19 are actually
After years as a successful investment strategy, something has happened to blue chips over the last 5 years. Despite huge
In my time at University (which seems like a lifetime ago) I recall two types of lecturers: Those that guided
Very few activities in life are both worthwhile and easy, and investing is no exception. While jumping on the latest